Health Care Reform

Although the GLP-1 drug Zepbound has been shown to be effective in promoting weight loss, availability and price have been barriers to more widespread use by patients.

Immediately, Trump's new Health appointees were met with a rash of strong reactions from assorted media outlets.

Two Competitive Enterprise Institute antitrust specialists say the agency never showed that PBMs are increasing patients' costs.

The three giants charge less than the guppies but report higher, more consistent profits, according to a new Health Affairs study.

CVS has been hit with at least three federal class actions, including two antitrust cases accusing CVS Caremark Corp. and other pharmacy benefit managers, the intermediaries between insurance companies and pharmacies, of price-fixing prescription drug reimbursement rates.

Plans in some markets cover a much higher percentage of the working-age population than in others.